Alfuzosin: A Review of the Therapeutic Use of the Prolonged-Release Formulation Given Once Daily in the Management of Benign Prostatic Hyperplasia

Author： McKeage K. Plosker G.L.

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.4, 2002-04, pp. : 633-653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Once-Daily Alfuzosin on Urinary Symptoms and Flow Rate in Benign Prostatic Hyperplasia: A 24-Hour Home-Uroflowmetry Evaluation

By Cosimo De Nunzio Franco Giorgio Leonardo Costantino Trucchi Alberto Tubaro Andrea Laurenti Cesare

Clinical Drug Investigation, Vol. 25, Iss. 6, 2005-01 ,pp. : 359-365

Adis International

Access to resources Recommend Favorite

Doxazosin Gastrointestinal Therapeutic System: A Review of its Use in Benign Prostatic Hyperplasia

By Goldsmith David R. Plosker Greg L.

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 2037-2047

Adis International

Access to resources Recommend Favorite

Alfuzosin for the management of benign prostate hyperplasia

By Weiner David M Lowe Franklin C

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2057-2063

Informa Healthcare

Access to resources Recommend Favorite

A Comparative Study on the Safety and Efficacy of Tamsulosin and Alfuzosin in the Management of Symptomatic Benign Prostatic Hyperplasia: a Randomized Controlled Clinical Trial

By Lapitan MCM Acepcion V Mangubat J

The Journal of International Medical Research, Vol. 33, Iss. 5, 2005-09 ,pp. : 562-573

Field House Publishing

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Once-Daily Molsidomine: From Immediate-Release to Prolonged-Release Once-Daily Formulations

By Herchuelz A.

American Journal of Drug Delivery, Vol. 2, Iss. 2, 2004-01 ,pp. : 131-141

Adis International

Access to resources Recommend Favorite